News Releases :: Sutro Biopharma, Inc. (STRO)

Apr 20, 2021 7:00 am EDT

Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer

Apr 15, 2021 7:00 am EDT

Sutro Biopharma Earns Milestone Payment from Cytokine Derivatives Collaboration with Merck

Apr 8, 2021 7:00 am EDT

Sutro Biopharma to Present at Two Upcoming Investor Conferences

Mar 22, 2021 7:00 am EDT

Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board

Mar 18, 2021 7:00 am EDT

Sutro Biopharma Reports Full Year 2020 Financial Results and Provides Business Highlights and 2021 Anticipated Milestones

Feb 23, 2021 7:00 am EST

Sutro Biopharma to Participate in the Cowen 41st Annual Healthcare Conference

Jan 21, 2021 7:00 am EST

Sutro Biopharma Announces First Patient Dosed in the Dose-Expansion Study of STRO-002 in Patients with Ovarian Cancer

Jan 5, 2021 7:00 am EST

Sutro Biopharma to Present at the 39th Annual J.P. Morgan Virtual Healthcare Conference

Dec 11, 2020 4:01 pm EST

Sutro Biopharma Announces Closing of Upsized $144.9 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Dec 8, 2020 9:10 pm EST

Sutro Biopharma Announces Pricing of $126.0 Million Public Offering